-
2
-
-
0346787790
-
Vaccines against papillomavirus infections and disease
-
Villa LL. Vaccines against papillomavirus infections and disease. Salud Publica Mex 2003;45:S443-8.
-
(2003)
Salud Publica Mex
, vol.45
-
-
Villa, L.L.1
-
5
-
-
33748113494
-
Fresh from the pipeline: Quadrivalent human papillo-mavirus recombinant vaccine
-
Crum C, Jones C, Kirkpatrick P. Fresh from the pipeline: Quadrivalent human papillo-mavirus recombinant vaccine. Nat Rev Drug Discov 2006;5:629-30.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 629-630
-
-
Crum, C.1
Jones, C.2
Kirkpatrick, P.3
-
6
-
-
34548663512
-
-
Gardasil® [Quadrivalent Human Papillomavirus (type 6,11,16.18) recombinant vaccine]. Merck and CO, Inc. White House Station: USA; 2006.
-
Gardasil® [Quadrivalent Human Papillomavirus (type 6,11,16.18) recombinant vaccine]. Merck and CO, Inc. White House Station: USA; 2006.
-
-
-
-
7
-
-
17444368112
-
The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: Consequences for clinical management
-
Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: Consequences for clinical management. Eur J Gynaecol Oncol 2005;26:129-42.
-
(2005)
Eur J Gynaecol Oncol
, vol.26
, pp. 129-142
-
-
Brinkman, J.A.1
Caffrey, A.S.2
Muderspach, L.I.3
Roman, L.D.4
Kast, W.M.5
-
8
-
-
0036559896
-
Papillomaviruses and cancer: From basic studies to clinical application
-
zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 342-350
-
-
zur Hausen, H.1
-
9
-
-
33646421976
-
Prophylactic human papillomavirus vaccines
-
Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J Clin Invest 2006;116:1167-73.
-
(2006)
J Clin Invest
, vol.116
, pp. 1167-1173
-
-
Lowy, D.R.1
Schiller, J.T.2
-
11
-
-
24644518036
-
Vaccines against human papillomavirus and cervical cancer: Promises and Challenges
-
Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: Promises and Challenges. Oncologist 2005;10:528-38.
-
(2005)
Oncologist
, vol.10
, pp. 528-538
-
-
Mahdavi, A.1
Monk, B.J.2
-
12
-
-
33747038742
-
Human papillomavirus prophylactic vaccines: Stakes and perspectives
-
Hantz S, Alain S, Denis F. Human papillomavirus prophylactic vaccines: Stakes and perspectives. Gynecol Obstet Fertil 2006;34:647-55.
-
(2006)
Gynecol Obstet Fertil
, vol.34
, pp. 647-655
-
-
Hantz, S.1
Alain, S.2
Denis, F.3
-
13
-
-
20944448032
-
-
Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
-
Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
-
-
-
-
14
-
-
0037153042
-
A controlled trial of a human papilloma virus type 16 vaccine
-
Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papilloma virus type 16 vaccine. N Engl J Med 2002;347:1645-51.
-
(2002)
N Engl J Med
, vol.347
, pp. 1645-1651
-
-
Koutsky, L.A.1
Ault, K.A.2
Wheeler, C.M.3
Brown, D.R.4
Barr, E.5
Alvarez, F.B.6
-
15
-
-
33644849136
-
Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: A randomized controlled trial
-
Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: A randomized controlled trial. Obstet Gynecol 2006;107:18-27.
-
(2006)
Obstet Gynecol
, vol.107
, pp. 18-27
-
-
Mao, C.1
Koutsky, L.A.2
Ault, K.A.3
Wheeler, C.M.4
Brown, D.R.5
Wiley, D.J.6
-
16
-
-
33746839247
-
-
Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16 and 18. Vaccine 2006;24:5571-83.
-
Villa LL, Ault KA, Giuliano AR, Costa RL, Petta CA, Andrade RP, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16 and 18. Vaccine 2006;24:5571-83.
-
-
-
-
17
-
-
33748541969
-
HPV vaccines: Now that they.re here, how do we maximize their benefit? Contrception
-
Myers ER. HPV vaccines: Now that they.re here, how do we maximize their benefit? Contrception 2006;74:277-9.
-
(2006)
, vol.74
, pp. 277-279
-
-
Myers, E.R.1
-
18
-
-
34548669345
-
-
Drugs approved by the FDA. Drug Name: Gardasil (quadrivalent human papillomavirus types 6,11,16,18) recombinant vaccine. Center watch newly approved drug therapies listing, Center Watch, Inc: 2006.
-
Drugs approved by the FDA. Drug Name: Gardasil (quadrivalent human papillomavirus types 6,11,16,18) recombinant vaccine. Center watch newly approved drug therapies listing, Center Watch, Inc: 2006.
-
-
-
-
19
-
-
33644979457
-
Preventing cervical cancer in the developing world
-
Katz IT, Wright AA. Preventing cervical cancer in the developing world. N Engl J Med 2006;354:1110.
-
(2006)
N Engl J Med
, vol.354
, pp. 1110
-
-
Katz, I.T.1
Wright, A.A.2
|